DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Intranasal COVID vaccine: Bharat Biotech seeks DCGI nod for phase 3 study of iNCOVACC in 5-18 age group Ruchika Sharma12 Sept 2022 11:28 AM ISTiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
Intranasal COVID vaccine INCOVACC will be global game changer, says Bharat Biotech Chairman Roshni Dhar8 Sept 2022 3:56 PM ISTBharat Biotech's iNCOVACC, the world's first intranasal vaccine for Covid-19 which received approval for emergency use in India on Tuesday, will be a...
Health Bulletin 7/September/2022 Roshni Dhar7 Sept 2022 5:00 PM ISTHere are the top health stories for the day:NEET PG 2022 counselling expected to commence from September 19Putting an end to the long wait by the...
Sapigen Biologix, Technology Development Board collaborate for malaria, COVID nasal vaccine Ruchika Sharma28 March 2022 11:00 AM ISTNew Delhi: The Technology Development Board (TDB) of the Union Ministry of Science and Technology and Sapigen Biologix Private Limited, Hyderabad on...
Bharat Biotech seeks DCGI nod for study of intra-nasal COVID vaccine as booster dose Ruchika Sharma21 Dec 2021 12:00 PM ISTNew Delhi: Indian vaccine maker Bharat Biotech said on Monday it has submitted an application to the country's drug regulator to conduct a late-stage...
